MMP9 and multiminicore myopathy: have reported that the level of MMP‐9 in the serum of patients with hemorrhagic MMD is higher than that in patients with ischemic MMD, indicating that MMP‐9 may serve as a biomarker for predicting hemorrhage in MMD.29